Artificial Intelligence and Real-World Data: The Duo That’s Reshaping Drug Development

Oct 16, 2025 | Blog

In today’s era of exponential data growth, real-world data (RWD) is abundant, but its value hinges on our ability to interpret it with speed, scale, and precision. That’s where artificial intelligence (AI) comes into play. At TriNetX, we’re seeing firsthand how the...

TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

Oct 15, 2025 | Press Releases

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.    CAMBRIDGE Mass., October 15, 2025 — TriNetX, driven by its vision of a connected world where data and...

Overcoming AI Risk and Inertia to Build Data-Driven Clinical Trials of Tomorrow

Oct 13, 2025 | Inside the Trends

Clinical research is at a crossroads. The technology exists, the data is available, and the ambition is clear, but adoption of truly integrating Artificial Intelligence (AI) and data-driven trials often stalls due to risk, trust, and organizational inertia. In this...

Clinical Trial Representativeness: Sanofi’s Dr. Monique Adams on Real-World Data and Inclusive Research

Oct 10, 2025 | Blog

As I sat down with Dr. Monique Adams of Sanofi for our most recent episode of The Future Prescription: Inside the Trends vodcast, I was reminded just how critical it is to move conversations about representativeness in clinical trials from aspiration to action....

Proof in Publications – The Most Cited. The Most Trusted. TriNetX Real-World Data.

Oct 9, 2025 | Blog

Download the Infographic The Most Cited. The Most Trusted. TriNetX Real-World Data Leading the Way. TriNetX is the most cited EHR dataset in peer-reviewed publications. Cited more often, by more researchers, than our top competitors Outpacing the field by a wide...

Designing Clinical Trials for Diversity, Inclusion & Representativeness

Sep 30, 2025 | Inside the Trends

How can clinical research move from talking about diversity to embedding representativeness as a foundation of trial design? In this episode of The Future Prescription: Inside the Trends, industry leaders explore how equitable design can transform science, improve...

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

Sep 29, 2025 | Press Releases

Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation.    CAMBRIDGE Mass., September 25, 2025 — TriNetX, the company behind the world’s broadest federated...

Putting Patients First: A Conversation with Ora on the Future of Clinical Trials

Sep 22, 2025 | Blog

In my role at TriNetX, I have the privilege of engaging with leaders across the clinical research landscape who are challenging the status quo and pushing us toward a more inclusive, tech-enabled, and patient-first future. One of the most rewarding conversations I’ve...

Care Reimagined: The Shift Toward Patient-Centric Research

Sep 12, 2025 | Inside the Trends

What happens when clinical research is redesigned around the needs, preferences, and lives of real people? In this episode of The Future Prescription: Inside the Trends, discover how sponsors and CROs are aligning clinical and commercial priorities to create smarter,...

Inclusion Is the New Standard: Biopharma’s Push for More Representative Clinical Trials

Sep 8, 2025 | Blog

As clinical trials evolve, one thing is certain: representativeness is no longer a nice-to-have; it’s a non-negotiable. The data are clear. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, 84% reported ramping up efforts to improve...